Latest News for: glp

Edit

Cheapest Compounded Semaglutide Without Insurance in 2026: What "Low-Cost" GLP-1 Pricing Often Excludes — SynergyRx ...

Nasdaq Globe Newswire 23 Jan 2026
Cheapest Compounded Semaglutide without insurance 2026. What low-cost GLP-1 pricing often excludes from total monthly cost—consumer framework ... .
Edit

CoreAge Rx Introduces Flat-Rate Pricing for GLP-1 Medications

Image Guymon Daily Herald 23 Jan 2026
... predictable costs for patients seeking GLP-1 medications.
Edit

Stopping GLP-1 drugs like Ozempic often does not mean weight regain, US research suggests

South China Morning Post 23 Jan 2026
Many patients using highly effective GLP-1 drugs may not regain lost weight quickly when they stop ...
Edit

Many patients may keep off lost pounds after stopping a GLP-1, U.S. data suggests

CTV 22 Jan 2026
Many patients using highly effective GLP-1 drugs ...
Edit

From GLP-1s to engineered probiotics: New research highlights evolving IBD care (AGA - American Gastroenterological Association Inc)

Public Technologies 22 Jan 2026
Real-world studies link GLP-1 drugs to improved IBD outcomes ... GLP-1 therapies are widely prescribed for obesity and diabetes, but their effects on IBD have remained largely unexplored.
Edit

Bending the obesity curve with GLP-1 RAs: How well does India understand obesity?

The Times of India 22 Jan 2026
Tackling it early with scientific and holistic care can prevent it from progressing into serious complications3.GLP-1 RAs to the rescueDespite the scale of the obesity crisis, awareness about medical treatments for obesity remains astonishingly low.
Edit

The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era

The Call 22 Jan 2026
This policy shift is expected to open the floodgates for millions of new patients, further solidifying Lilly's revenue trajectory for the remainder of the year.Winners and Losers in the GLP-1 Arms Race.
Edit

GLP-3s, monthly skinny pens and next leap in obesity drugs in 2026

India Today 21 Jan 2026
GLPs monthly skinny pens and next leap in obesity drugs in ... .
Edit

Beyond the Bald Truth: Rejecting Big Pharma’s GLP-1 Gamble for Natural, Lifelong Health

Natural News 21 Jan 2026
Introduction. The High Cost of Quick FixesIn the frenzied pursuit of rapid weight loss, millions have turned to GLP-1 drugs like Ozempic and Wegovy,... .
Edit

Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s

CNBC 21 Jan 2026
Structure Therapeutics CEO Ray Stevens talked about the biotech’s path forward and his expectations for the future of the booming GLP-1 space ... .
Edit

Swiss pharma giant vows to double spending at future Wake County GLP-1 plant

The Herald-Sun 21 Jan 2026
Roche’s bet on weight-loss drugs comes a month after its subsidiary Genentech struck a deal with the Trump administration to avoid tariffs ... .
Edit

Health Canada warns about fake or unauthorized versions of GLP-1 drugs

CBC 21 Jan 2026
Health Canada is warning people not to buy or use fake or ...
×